Category: Antisense & RNAi Technology
Global Antisense & RNAi Technology
-
RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious Diseases, Rare Genetic Diseases), End User (Hospitals & Clinics) - Global Forecast to 2028
... projected to grow from USD 13.7 billion in 2023 to USD 18.0 billion by 2028 at a CAGR of 5.6%. The key factors driving the overall market growth include an increase in the number of ... Read More
-
Global RNAi Technology Market - 2023-2030
... period 2023-2030. Small nucleic acid fragments are employed in RNA interference (RNAi), a technology, to post-transcriptionally silence genes and treat cancer and other disorders. Through the use of this technology, proteins that lack the enzyme ... Read More
-
Global miRNA Market 2023-2027
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
RNAi Drug Delivery: Technologies and Global Markets
... are divided into polymers, lipids and others (e.g., inorganic material, hybrid systems). The market is also segmented based on the molecule types, delivery modes and therapeutic areas. It is divided by application types into therapeutic ... Read More
-
Gene Editing Market by Product & Service (Reagents, Consumables, Systems, Software), Technology (CRISPR, TALEN, ZFN, Antisense), Application (Cell Line Engineering, Genetic Engineering, Drug Discovery), End User (Pharma, Biotech) – Global Forecast to 2028
... editing market is projected to grow from USD 5.3 billion in 2023 to USD 10.6 billion by 2028 at a CAGR of 15.0%. Rising government funding and number of genomics projects has emerged as a ... Read More
-
Global RNAi Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. This ... Read More
-
Global RNAi Therapy Supply, Demand and Key Producers, 2023-2029
... (2023-2029). This report studies the global RNAi Therapy demand, key companies, and key regions. This report is a detailed and comprehensive analysis of the world market for RNAi Therapy, and provides market size (US$ million) ... Read More
-
Genome Editing Market Forecasts to 2028 – Global Analysis By Product & Service (Reagents & Consumables, Services, Software & Systems, Cell Lines and Other Product & Services), By Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Zinc Finger Nuclease (ZFN), Transcription Activator-Like Effector Nuclease (TALEN), Antisense, Restriction Enzymes and Other Technologies), By Application (Cell Line Editing, Genetic Engineering, Drug Discovery & Development, Diagnostic Applications, Microorganisms Genetic Engineering, Gene Therapy and Other Applications), By End User (Clinical Research Organizations, Academics & Government Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organization and Other End Users) and By Geography
... (CRISPR), Zinc Finger Nuclease (ZFN), Transcription Activator-Like Effector Nuclease (TALEN), Antisense, Restriction Enzymes and Other Technologies), By Application (Cell Line Editing, Genetic Engineering, Drug Discovery & Development, Diagnostic Applications, Microorganisms Genetic Engineering, Gene Therapy and ... Read More
-
RNA Interference (RNAi) Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... IMARC Group expects the market to reach US$ 235.1 Billion by 2028, exhibiting a growth rate (CAGR) of 21.4% during 2023-2028. Ribonucleic acid interference (RNAi) drug delivery refers to a therapeutic solution to monitor gene ... Read More
-
Global RNAi for Therapeutic Market Research Report 2023(Status and Outlook)
... Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. ... Read More
-
Global Antisense and RNAi Therapeutics Market Report and Forecast 2023-2031
... market is anticipated to grow at a CAGR of 8.5% during the forecast period of 2023-2031 to attain a value of USD 3.56 billion by 2031. Antisense and RNAi Therapeutics Market: Introduction Antisense and RNAi ... Read More
-
Global Antisense and RNAi Therapeutics Drug Market Growth (Status and Outlook) 2023-2029
... it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Antisense and RNAi Therapeutics Drug is estimated to increase from US$ million in 2022 to US$ million ... Read More
-
Investor Series: Opportunities in RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers)
... provide more effective treatment options for a wide range of disorders, with fewer side effects. These therapies are currently being developed using different types of RNA-based molecules, including coding RNAs (such as mRNA) and non-coding ... Read More
-
Global RNAi Medicine Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. United States market for RNAi Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Global RNA Interference (RNAi) Drug Delivery Market Growth 2023-2029
... Delivery sales in 2022, providing a comprehensive analysis by region and market sector of projected RNA Interference (RNAi) Drug Delivery sales for 2023 through 2029. With RNA Interference (RNAi) Drug Delivery sales broken down by ... Read More
-
RNAi Therapeutics Market Analysis And Forecast To 2032: Type (Small Interfering RNAS, Microrna), Application (Genetic Disorder, Oncology, Neurodegenerative Disorder, Cardiovascular Disorder, Respiratory Disorder, Neurodegenerative Disorders, Renal Disease, Other), Route of Administration (Intradermal Injections, Pulmonary Delivery, Intravenous Injections, Intraperitoneal Injections, Topical Delivery, Others), And Region
... A brand-new class of drugs based on ribonucleic acid is known as RNA therapies (RNA). Target mRNA molecules are neutralized during the biological process known as RNA interference, and RNA molecules are then shown to ... Read More
-
Global Antisense & RNAi Therapeutics Market Growth (Status and Outlook) 2023-2029
... causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate ... Read More
-
High Content Imaging Market
... grew from USD 847.54 Billion in 2022 tUSD 847.54 Billion by 3032, exhibiting a CAGR of 11.4% during the forecast period. In addition, the study includes supply and demand risk, market attractiveness, BPS analysis, and ... Read More
-
Global RNAi for Therapeutic Market Growth (Status and Outlook) 2023-2029
... was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is ... Read More
-
Oligonucleotide Synthesis Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product & Services (Oligonucleotide Synthesis Products (Oligonucleotide Synthesis Equipment - Synthesizers, Oligonucleotide Synthesis Reagents & Consumables), Synthesized Oligonucleotides (Pre-Designed Oligonucleotides - Primers, Probes, Linkers & Adaptors), Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide - Large-Scale Oligonucleotide Synthesis, Intermediate-Scale Oligonucleotide Synthesis, Small-Scale Oligonucleotide Synthesis); By Application (Research (PCR, qPCR/RTqPCR, Sequencing, Gene Synthesis, Other Research Applications), Therapeutics (RNAi Oligonucleotide-based Therapies, DNA/Antisense oligonucleotide-based Therapies, Immunotherapy (CpG Oligonucleotide-based Therapies), Nucleic Acid Aptamers), Diagnostics); By End User (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, Others); By Re
... Oligonucleotides - Primers, Probes, Linkers & Adaptors), Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide - Large-Scale Oligonucleotide Synthesis, Intermediate-Scale Oligonucleotide Synthesis, Small-Scale Oligonucleotide Synthesis); By Application (Research (PCR, qPCR/RTqPCR, Sequencing, Gene Synthesis, Other Research Applications), Therapeutics ... Read More
-
mRNA Vaccines and RNAi Therapeutics Market By Disease Type (Hereditary transthyretin-mediated amyloidosis genetic, Acute hepatic porphyria, Primary hyperoxaluria type 1, Atherosclerotic cardiovascular disease), By Route of administration (IV infusion, Subcutaneous), By End user (Research Institutes, Hospitals and clinics): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Hospitals and clinics): Global Opportunity Analysis and Industry Forecast, 2021-2031 The single protein-coding gene known as messenger ribonucleic acid (mRNA) is located in the genome and provides the basis for how cells make proteins. Mammalian ... Read More
-
2022 Global Forecast for Antisense And Rnai Therapeutics Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material ... Read More
-
The 2023-2028 World Outlook for RNAi Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for RNA Interference (RNAi) Technologies
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Drug Discovery and Development RNA Interference (RNAi)
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
Research Assistance
